LANTUS- insulin glargine injection, solution LANTUS SOLOSTAR- insulin glargine injection, solution sanofi-aventis U.S
Secondary outcomes Secondary outcomes included cardiovascular mortality, all-cause mortality, non-fatal myocardial infarction (MI) and stroke, as well as hospitalisation for heart failure
The Lancet 392, 15191529
Its integrated platform connects 6,500+ pharmacies (the Wellgistics Pharmacy Network) and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access
These shifts are rarely dramatic enough to prompt a doctor's visit but they are consistent, and they are physiological